The hyper-acquisitive multinational pharmaceutical company Allergan is buying the fat-reduction biopharmaceutical company Zeltiq Aesthetics. Allergan, which is the Dublin-headquartered maker of Botox, ...

PLEASANTON — Zeltiq Aesthetics has struck a $2.48 billion deal for Botox-maker Allergan to buy the company and its CoolSculpting technology, which reduces fat. The deal is expected to close during the ...

The company behind the CoolScuplting fat cell freezing platform delivers another quarter of growth. It's revising its revenue guidance higher, again. Revenue checked in at $64.5 million during the ...

The company behind the CoolScuplting fat cell freezing platform delivers another quarter of growth. It's revising its revenue guidance higher, again. Revenue hit a record $95.2 million during Zeltiq's ...

Zeltiq fights fat by freezing cells, causing them to self-destruct. Sept. 15, 2010— -- If you can't diet or exercise it off, you can now try to freeze or zap it off. The Food and Drug ...

NEW YORK (AP) -- Shares of Zeltiq Aesthetics Inc. surged Tuesday after the company posted stronger second-quarter sales of its CoolScuplting body fat sculpting system. Zeltiq's CoolSculpting system is ...

Zeltiq Aesthetics(NASDAQ: ZLTQ)has carved out a cozy living by making people feel better about the way they look on the outside, making Zeltiq's insides look pretty good in the process. Shares of ...

This post is part of an ongoing effort to crowd-source a repeating feature in Forbes magazine entitled Names You Need to Know. We are looking for the people, places, products and ideas that will have ...

PLEASANTON, CA--(Marketwired - February 29, 2016) - ZELTIQ ®, (ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling ...

ZELTIQ ®(ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced financial results for ...

Botox maker Allergan is spending about $2.48 billion to buy Zeltiq Aesthetics Inc. and its CoolSculpting system for reducing fat. Allergan said it will pay $56.50 for each share of Zeltiq in a deal it ...